Atlas Trials

A Prospective Epidemiologic Study of ALK-Positive NSCLC in China

Clinical trial NCT02042105 · COMPLETED

Trial details

NCT number
NCT02042105
Sponsor
Guangdong Association of Clinical Trials
Status
COMPLETED
Study type
OBSERVATIONAL
Non-small-cell Lung Cancer
Start date
2013-11-11
Primary completion
2015-04-15
Enrollment
3649

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.